Aptamer-based array (n=1839 human proteins biomarkers)
1. Protein levels in vaccinated and unvaccinated SARS-CoV-2 patients in the acute and recovery phases of
infection
A) Beeswarm plot (with medians) for unvaccinated patients (n=66) & vaccinated patients(n=24) in the acute phase of infection and HC (n=20)
The p-values are adjusted for age, gender, race, and
days from symptoms onset based on rank-based inverse normal transformation of the biomarker value.
FDR-adjusted p value (adjusted over 7288 proteins) is shown for each pairwise comparison.
B) Linear plot (with medians) for unvaccinated patients (n=22) & vaccinated patients (n=10) in the
acute and recovery phases of infection and healthy controls (n=20)
The p-values are adjusted for age, gender, and race on rank-based inverse normal transformation of the biomarker value.
FDR-adjusted p value (adjusted over 7288 proteins) is shown for each pairwise comparison.
2. Protein levels in four clusters of SARS-CoV-2 patients identified via hierarchical clustering and
healthy controls in the acute and recovery phases of infection
A) Beeswarm plot (with medians) for four clusters of SARS-CoV-2 patients (n=90) in the acute phase of infection and healthy controls (n=20)
The p-values are adjusted for age, gender, and race on
rank-based inverse normal transformations of the biomarker value, with FDR-adjusted p value (adjusted over 7288 proteins)
B) Linear plot (with medians) for four clusters of SARS-CoV-2 patients (n=32) in the acute and
recovery phases of infection and healthy controls (n=20)
Aptamer-based array (n=1500 human proteins biomarkers)
1. Protein levels in vaccinated and unvaccinated SARS-CoV-2 patients in the convalescent phase of infection
The p-values are adjusted for age, gender, and race based on rank-based
inverse normal transformation of the biomarker value. FDR p value (adjusted over 1500 proteins)
is shown for each pairwise comparison.
2. Longitudinal trend over 3 phases (acute, recovery, and convalescent) in SARS-CoV-2 patients
A) Beeswarm plot (with medians) for SARS-CoV-2 patients (n=30) in all phases and healthy controls (n=20)
B) Linear plot (with medians) for SARS-CoV-2 patients (n=30) in all phases and healthy controls (n=20)
Aptamer-based array (n=1500 human proteins biomarkers)
Protein levels in vaccinated SARS-CoV-2 patients with mild breakthrough infections in the acute and convalescent phases of infection
A) Beeswarm plot (with medians) for Omicron patients (n=26) & Pre-Omicron (n=14) in the acute phase of infection and healthy controls (n=20)
B) Linear plot (with medians) for Omicron patients (n=20) in the acute and convalescent phases of infection and healthy controls (n=20)